Prof. Markku Savolainen is Professor (emeritus) of Internal Medicine at the University of Oulu.
Prof. Savolainen received his MD degree in Oulu in 1975 and his PhD degree in 1977. He was a research fellow at the Mount Sinai School of Medicine, New York, USA, from 1981 to 1983. After that he specialised into internal medicine.
His research interests have been focussed around lipoproteins, especially HDL. In addition to the basic research approach, prof. Savolainen has been principal investigator of many clinical trials involving patients with overweight, obesity, type 2 diabetes, hyperlipidaemia and other risk factors of coronary heart disease. To date, he has published more than 200 research papers in international peer-reviewed journals.
Professor Savolainen has been the leader of a large consortium of the SALVE research programme ("Public Health Challenges") of the Academy of Finland. He was also involved in the Scandinavian SYSDIET consortium where healthy subjects consumed either new Nordic diet or conventional diet. More recently the research focus is on lifestyle change counselling and the use of ICT-based technology in implementing it to public healthcare.